Who invested in OrthoAccel Technologies?
OrthoAccel Technologies's investors include Houston Angel Network, S3 Ventures, HealthpointCapital, Comerica Bank and S3 Ventures.
United States · Venture startup
12 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$41Mraised across 12 rounds since 2007, from 12 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $5.0M sold, first sale Nov 2014
From a historical funding recordSEC filing: $5.0M sold, first sale Jan 2014
From a historical funding recordSEC filing: $5.0M sold, first sale Jan 2014
From a historical funding recordSEC filing: $13M sold, first sale Apr 2012
Reported by finsmes.comSEC filing: $11M sold, first sale Apr 2012
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Jul 2009
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
OrthoAccel Technologies's investors include Houston Angel Network, S3 Ventures, HealthpointCapital, Comerica Bank and S3 Ventures.
OrthoAccel Technologies has raised $41M across 12 rounds since 2007. One round did not disclose an amount, so the total is a floor.
OrthoAccel Technologies's most recent round was a Venture of $5.0M in Jan 2015.
OrthoAccel Technologies's largest round on record is $13M (Series B), in May 2013.
OrthoAccel Technologies's first round on record, in Dec 2007, was backed by Houston Angel Network.
OrthoAccel Technologies's latest named round is a Venture, in Jan 2015.
OrthoAccel Technologies is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.